Skip to main content
. 2021 Sep 14;18(9):e1003761. doi: 10.1371/journal.pmed.1003761

Table 1. Demographics, injury mechanism, comorbidity, and presenting physiology of 21,681 TBI patients enrolled in the CENTER-TBI Registry.

Characteristic Overall High-energy TBI Low-energy TBI p-Value
Total 21,681 13,059 (60.2) 8,622 (39.8)
Demographic characteristics
Age (years), median (IQR) 55 (32–75) 42 (25–60) 74 (56–84) <0.001a
Age
 Under 16 years 579 (2.7) 488 (3.7) 91 (1.1) <0.001b
 16–64 years 12,782 (59.0) 9,934 (76.1) 2,848 (33.0)
 65 years and over 8,317 (38.4) 2,635 (20.2) 5,682 (65.9)
Male
 Overall 13,186 (60.8) 8,833 (67.6) 4,353 (50.5) <0.001b
 Under 16 years 371 (64.1) 316 (64.8) 55 (60.4) <0.001b
 16–64 years 8,831 (69.1) 7,044 (70.9) 1,787 (62.7)
 65 years and over 3,982 (47.9) 1,472 (55.9) 2,510 (44.2)
Place of injury
Street/highway 7,324 (33.8) 6,328 (48.5) 996 (11.6) <0.001b
Home/domestic 8,295 (38.3) 2,860 (21.9) 5,435 (63.0)
Work/school 746 (3.4) 587 (4.5) 159 (1.8)
Sport/recreational 721 (3.3) 671 (5.1) 50 (0.6)
Public location 3,394 (15.7) 2,000 (15.3) 1,394 (16.2)
Other 735 (3.4) 308 (2.4) 427 (5.0)
Unknown 448 (2.1) 292 (2.2) 156 (1.8)
Missing 18 (0.1) 13 (0.1) 5 (0.1)
Pre-injury health status and medical history
Normal healthy patient 8,688 (40.1) 7,285 (55.8) 1,403 (16.3) <0.001b
Mild systemic disease 6,266 (28.9) 3,391 (26.0) 2,875 (33.3)
Severe systemic disease 5,105 (23.5) 1,569 (12.0) 3,536 (41.0)
Life-threatening disease 523 (2.4) 116 (0.9) 407 (4.7)
Taking anticoagulants 2,578 (11.9) 744 (5.7) 1,834 (21.3) <0.001b
Taking platelet aggregate inhibitors 2,466 (11.4) 783 (6.0) 1,683 (19.5) <0.001b
Taking both anticoagulants and platelet aggregate inhibitors 370 (1.7) 120 (0.9) 250 (2.9) <0.001b
Intracranial lesions and taking anticoagulants 580 (11.7) 207 (6.5) 373 (20.9) <0.001b
Intracranial lesions and taking platelet aggregate inhibitors 679 (13.7) 269 (8.5) 410 (23.0) <0.001b
Intracranial lesions and taking both anticoagulants and platelet aggregate inhibitors 114 (2.3) 37 (1.2) 77 (4.3) <0.001b
ED arrival physiology
GCS, median (IQR)c 15 (14–15) 15 (14–15) 15 (14–15) <0.001a
GCS
 Mild TBI (GCS 13–15) 17,702 (81.6) 10,270 (78.6) 7,432 (86.2)
 Moderate TBI (GCS 9–12) 830 (3.8) 480 (3.7) 350 (4.1)
 Severe TBI (GCS 3–8) 1,195 (5.5) 879 (6.7) 316 (3.7)
 No sum 1,835 (8.5) 1,366 (10.5) 469 (5.4)
Hypoxiac 287 (1.3) 183 (1.4) 104 (1.2) 0.219b
Hypotensionc 434 (2.0) 322 (2.5) 112 (1.3) <0.001b
Pupillary reactivityc <0.001b
 Neither reacting 552 (2.5) 419 (3.2) 133 (1.5)
 One reacting 483 (2.2) 313 (2.4) 170 (2.0)
 Both reacting 19,409 (89.5) 11,694 (89.5) 7,715 (89.5)

Data are n (%) unless otherwise indicated.

aBy Mann–Whitney test for non-parametric variable distributions.

bBy chi-squared test.

cMissing data percentage is 5.0%–10% for low- versus high-energy TBI comparison.

ED, emergency department; GCS, Glasgow Coma Score; IQR, interquartile range; TBI, traumatic brain injury.